Lipid profile alterations have been observed in patients with coronavirus disease 2019
(COVID-19) in relation to disease severity and mortality. We conducted a systematic review …

Summary Background Coronavirus disease-2019 (COVID-19) is a global pandemic. Studies
reported dyslipidemia in patients with COVID-19. Herein, we conducted a systematic review …

Abstract Background Coronavirus disease 2019 (COVID-19) pandemic continues to
escalate intensively worldwide. Massive studies on general populations with SARS-CoV-2 …

The significant morbidity and mortality associated with severe acute respiratory syndrome
coronavirus 2 infection has underscored the need for novel antiviral strategies. Lipids play …

Objectives D-dimer elevations, suggesting a pro-thrombotic state and coagulopathy, predict
adverse outcomes in coronavirus disease 2019 (COVID-19). However, the clinical …

The COVID-19 pandemic has led to over 100 million infections and over 3 million deaths
worldwide. Understanding its pathogenesis is crucial to guide prognostic and therapeutic …

Dyslipidemia is a fundamental risk factor for cardiovascular diseases (CVDs) and can
worsen the prognosis, if unaddressed. Lipid guidelines are still evolving as dyslipidemia is …

Background. Lipid profile and its related ratios such as total cholesterol (TC), low‐density
lipoprotein‐cholesterol (LDL‐C), triglyceride (TG), high‐density lipoprotein‐cholesterol (HDL …

Background Coronavirus disease 2019 (COVID-19) ranges from asymptomatic infection to
severe illness. Cholesterol in the host cell plasma membrane plays an important role in the …

COVID-19 infections decrease total cholesterol, LDL-C, HDL-C, and apolipoprotein AI, A-II,
and B levels while triglyceride levels may be increased or inappropriately normal for the …